title: Appropriateness of antiviral prescribing for influenza in primary care: a retrospective analysis.
abstract: OBJECTIVE
  Antiviral medications cost-effectively reduce influenza-related morbidity and potentially mortality. We sought to assess the appropriateness of antiviral prescribing for influenza.
  
  
  METHODS
  We performed a retrospective analysis of visits by adults to primary care clinics during influenza seasons from 1 October 2000 to 31 May 2004 with a claims diagnosis of influenza (n=535) or with an electronic antiviral prescription (n=25). We defined appropriate antiviral prescribing as the patient having (a) symptoms for 2 or fewer days, (b) fever and (c) any two of headache, sore throat, cough, or myalgias.
  
  
  CONCLUSIONS
  Physicians diagnosed patients with influenza in 102 of 535 (19%) visits with a claims diagnosis of influenza. Physicians prescribed antivirals at 15 of 102 (15%) of these visits. The addition of 25 additional electronic antiviral prescriptions gave a sample of 127 visits and 40 (31%) antiviral prescriptions. Twenty-eight (70%) antiviral prescriptions were appropriate. Among patients who did not receive antivirals, 21 of 87 (24%) met criteria for appropriate antiviral prescribing. Antiviral prescribing was associated with a shorter median symptom duration (2 days vs. 3 days; P<0.01) and higher median temperature (37.8 degrees C vs. 36.9 degrees C; P<0.01). Physicians prescribed antivirals more frequently to patients who had myalgias (37% vs. 18%; P=0.04) and an influenza test (67% vs. 28%; P<0.01). Physicians prescribed antivirals more frequently to Blacks (44%) and patients with other race/ethnicity (67%) than to Whites (20%) or Hispanics (20%; P<0.0001).
  
  
  CONCLUSIONS
  To improve antiviral prescribing for influenza in primary care, interventions need to target the accurate identification of influenza visits, undertreatment, as well as inappropriate treatment.
authors.affiliation: Division of General Medicine and Primary Care, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02120, USA. jlinder@partners.org
authors.forename: J A
authors.initials: JA
authors.lastname: Linder
authors.forename: J C
authors.initials: JC
authors.lastname: Chan
authors.forename: D W
authors.initials: DW
authors.lastname: Bates
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D016208:Databases, Factual; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D004363:Drug Utilization; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D008137:Longitudinal Studies; D008499:Medical Records; D012189:Retrospective Studies; D012959:Socioeconomic Factors
chemical_list: D000998:Antiviral Agents